isatin has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devale, TL; Miniyar, P; Murumkar, P; Parikh, J; Sharma, P; Shrivastava, B | 1 |
| Coates, JA; Deadman, JJ; Francis, CL; Jeevarajah, D; Jones, ED; Le, G; Lucent, D; Newman, J; Peat, TS; Rhodes, DI; Ryan, JH; Savage, GP; Smith, JA; Thienthong, N; Vandegraaff, N; Winfield, LJ | 1 |
2 other study(ies) available for isatin and HIV Coinfection
| Article | Year |
|---|---|
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isatin; Molecular Docking Simulation; Pyrimidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2017 |
Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design.
Topics: Alkylation; Catalytic Domain; Crystallography; Dioxoles; Drug Design; HIV Infections; HIV Integrase Inhibitors; HIV-1; Indoles; Isatin; Ligands; Magnetic Resonance Spectroscopy; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance | 2011 |